The effectiveness of N-acetylcysteine in preventing contrast-induced nephropathy in patients undergoing contrast-enhanced computed tomography: a meta-analysis of randomized controlled trials

被引:0
|
作者
Mei-Yi Wu
Hui-Fen Hsiang
Chung-Shun Wong
Min-Szu Yao
Yun-Wen Li
Chao-Ying Hsiang
Chyi-Huey Bai
Yung-Ho Hsu
Yuh-Feng Lin
Ka-Wai Tam
机构
[1] Taipei Medical University,Division of Nephrology, Department of Internal Medicine
[2] Shuang Ho Hospital,Department of Nursing
[3] Taipei Medical University Hospital,Department of Emergency Medicine
[4] Taipei Medical University,Department of Radiology
[5] Shuang Ho Hospital,School of Public Health
[6] Taipei Medical University,Division of General Surgery, Department of Surgery
[7] Wan Fang Hospital,Center for Evidence
[8] Taipei Medical University,Based Medicine
[9] Taipei Medical University Hospital,undefined
[10] Taipei Medical University,undefined
来源
关键词
-Acetylcysteine; Contrast-induced nephropathy; Computed tomography; Meta-analysis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1309 / 1318
页数:9
相关论文
共 50 条
  • [21] Meta-Analysis: Effectiveness of Drugs for Preventing Contrast-Induced Nephropathy
    Kelly, A. M.
    Dwamena, B.
    Cronin, P.
    Bernstein, S. J.
    Carlos, R. C.
    JOURNAL OF UROLOGY, 2009, 181 (02): : 692 - 693
  • [22] Meta-analysis: Effectiveness of drugs for preventing contrast-induced nephropathy
    Kelly, Aine M.
    Dwamena, Ben
    Cronin, Paul
    Bernstein, Steven J.
    Carlos, Ruth C.
    ANNALS OF INTERNAL MEDICINE, 2008, 148 (04) : 284 - 294
  • [23] N-acetylcysteine for the prevention of contrast-induced nephropathy in patients undergoing primary angioplasty
    Lauri, G
    Marenzi, G
    Assanelli, E
    Marana, I
    Campodonico, J
    Grazi, M
    De Metrio, M
    Trabattoni, D
    Galli, S
    Bartorelli, AL
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (7A): : 42H - 42H
  • [24] Comparison of N-acetylcysteine and fenoldopam for preventing contrast-induced nephropathy (CAFCIN)
    Ng, Tien M. H.
    Shurmur, Scott W.
    Silver, Mary
    Nissen, Lindsay R.
    O'Leary, Edward L.
    Rigmaiden, Richard S.
    Cieciorka, Mike
    Porter, Laura L.
    Ineck, Beata A.
    Kline, Mary E.
    Puumala, Susan E.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2006, 109 (03) : 322 - 328
  • [25] Intravenous N-acetylcysteine for preventing contrast-induced nephropathy:: A randomised trial
    Carbonell, Nieves
    Blasco, Marisa
    Sanjuan, Rafael
    Perez-Sancho, Esther
    Sanchis, Juan
    Insa, Luis
    Bodi, Vicente
    Nunez, Julio
    Garcia-Ramon, Rafael
    Miguel, Alfonso
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 115 (01) : 57 - 62
  • [26] N-Acetylcysteine in Preventing Contrast-Induced Nephropathy Assessed by Cystatin C
    Alioglu, Emin
    Saygi, Serkan
    Turk, Ugur
    Kirilmaz, Bahadir
    Tuzun, Nurullah
    Duman, Can
    Tengiz, Istemihan
    Yildiz, Serkan
    Ercan, Ertugrul
    CARDIOVASCULAR THERAPEUTICS, 2013, 31 (03) : 168 - 173
  • [27] Prophylaxis of contrast-induced nephropathy with N-acetylcysteine
    Gawenda, M.
    Moeller, A.
    Wassmer, G.
    Brunkwall, J.
    ZENTRALBLATT FUR CHIRURGIE, 2007, 132 (03): : 227 - 231
  • [28] N-acetylcysteine in the prevention of contrast-induced nephropathy
    Fishbane, Steven
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 3 (01): : 281 - 287
  • [29] Nicorandil for the prevention of contrast-induced nephropathy: A meta-analysis of randomized controlled trials
    Ma, Xiaofen
    Li, Xiang
    Jiao, Zhanfeng
    Zhang, Yiming
    CARDIOVASCULAR THERAPEUTICS, 2018, 36 (02)
  • [30] Oral N-acetylcysteine for prophylaxis of contrast-induced nephropathy in patients following coronary angioplasty: A meta-analysis
    Li, Jing-Xiu
    Jin, En-Ze
    Yu, Long-Hao
    Li, Yang
    Liu, Nan-Nan
    Dong, Yu-Mei
    Li, Xin
    Li, Xue-Qi
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 14 (02) : 1568 - 1576